The price of Hims & Hers Health Inc (NYSE:HIMS) shares last traded on Wall Street fell -5.59% to $17.56.
HIMS stock price is now 25.55% away from the 50-day moving average and 84.35% away from the 200-day moving average. The market capitalization of the company currently stands at $3.77B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target reduced from $17 to $15, Jefferies Downgraded its rating from Buy to Hold for Hims & Hers Health Inc (NYSE: HIMS). On April 10, 2024, Canaccord Genuity recently initiated its ‘Buy’ rating on the stock quoting a target price of $20, while ‘Imperial Capital’ rates the stock as ‘Outperform’
In other news, Boughton Soleil, Chief Legal Officer sold 4,915 shares of the company’s stock on May 20 ’24. The stock was sold for $98,373 at an average price of $20.01. Upon completion of the transaction, the Chief Legal Officer now directly owns 159,357 shares in the company, valued at $2.8 million. An SEC document containing details of the transaction can be found on the SEC’s website. On May 17 ’24, PAO Becklund Irene sold 943 shares of the business’s stock. A total of $13,674 was realized by selling the stock at an average price of $14.50. A total of 32.05% of the company’s stock is owned by insiders.
During the past 12 months, Hims & Hers Health Inc has had a low of $5.65 and a high of $20.11. As of last week, the company has a debt-to-equity ratio of 0.03, a current ratio of 2.80, and a quick ratio of 2.48. The fifty day moving average price for HIMS is $14.0486 and a two-hundred day moving average price translates $9.57265 for the stock.
The latest earnings results from Hims & Hers Health Inc (NYSE: HIMS) was released for 2024-03-31. According to the Household & Personal Products Company, earnings per share came in at -0.03, beating analysts’ expectations of -0.05 by 0.02. This compares to -$0.05 EPS in the same period last year. The net profit margin was -0.25% and return on equity was -0.72% for HIMS. The company reported revenue of $278.17 million for the quarter, compared to $190.77 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 45.81 percent. For the current quarter, analysts expect HIMS to generate $295.35M in revenue.
